loading...| Preferred Name |
firsocostat |
| Synonyms |
2-(1-((2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl)-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno(2,3-d)pyrimidin-3-yl)-2-methylpropanoic acid |
| ID |
http://purl.bioontology.org/ontology/MESH/C000629250 |
| altLabel |
2-(1-((2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl)-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno(2,3-d)pyrimidin-3-yl)-2-methylpropanoic acid GS-0976 |
| cui |
C4743336 C4743337 |
| HM |
D011743 D058610 D010080 |
| Inverse of RB |
XE10NJQ95M |
| isa | |
| Mapped to |
http://purl.bioontology.org/ontology/MESH/D010080 |
| MDA |
20181210 |
| MeSH Frequency |
10 |
| MMR |
20181210 |
| notation |
C000629250 |
| PA |
D004791 |
| prefLabel |
firsocostat |
| SC |
1 |
| Scope Statement |
an inhibitor of acetyl-coenzyme A carboxylase in liver; for treatment of hepatic steatosis and fibrosis associated with nonalcoholic fatty liver disease |
| SRC |
Gastroenterology. 2018 Nov;155(5):1463-1473.e6. |
| TERMUI |
T000949453 T000949451 T000949452 |
| TH |
FDA SRS (2017) NLM (2019) INN (19XX) |
| tui |
T109 T121 |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C169983 | National Cancer Institute Thesaurus / 美国国家癌症研究所词典 | LOOM |